TP53 and breast carcinoma: Decreased survival of breast cancer patients with mut p53 and MDM2 elevation (mut TP53/high MDM2) strongly correlated with elevated levels of co-chaperone DNAJB1/HSP40 and selectively with other chaperones (Table 1).